A Dedication to Better Outcomes
We inspire trust, hope, and confidence through our work, delivering meaningful advancements in care that positively impact both patients and healthcare providers.
A Dedication to Better Outcomes
We inspire trust, hope, and confidence through our work, delivering meaningful advancements in care that positively impact both patients and healthcare providers.
About scPharma
The Difference
Dedication and Care
scPharmaceuticals is a publicly held company dedicated to advancing care in the cardiorenal space through integrated solutions. Our approach blends pharmaceuticals, drug-device combinations, and specialty products, all designed to deliver targeted treatments that improve patient outcomes.
Clinical Development, Commercial, and Regulatory Expertise
scPharmaceuticals’ expertise in clinical development, commercialization, and navigating regulatory requirements, including those for drug-device combination products, makes us the ideal partner for late-stage R&D companies looking to commercialize cardiorenal assets. We adhere to stringent regulatory and compliance standards, focusing on the safety and efficacy of our treatments through rigorous clinical trials, post-marketing surveillance, and strict adherence to regulatory guidelines.
Committed to advancing the field of cardiorenal medicine, we are continuously searching for new therapies that address unmet medical needs and improve cardiorenal patient outcomes. With a strategy for efficient launches and patient-centric care, we always strive for early commercial success.
What Sets Us Apart
Our difference lies in our unwavering focus on cardiorenal care. We offer holistic solutions tailored to unmet patient needs, with a commitment to accessible, high-quality treatments that raise the standard of care across the industry.
scPharmaceuticals in the Market
We are known for our relentless dedication to advancing care for cardiorenal conditions, continually addressing unmet needs through innovation and collaboration. scPharmaceuticals is a forward-thinking, reliable leader. Our commitment to patient-centric care builds trust and loyalty for our investors, partners, and across the healthcare stakeholder community.
Complex Condition Management
Our goal is to address risk, prevent disease progression, and manage complications effectively.
scPharmaceuticals focuses on the intricate connections between the heart and kidneys to develop therapies for patients with cardiorenal conditions such as chronic kidney disease (CKD) and heart failure.
See our flagship product, FUROSCIX® (furosemide injection) 80mg/10mL for Subcutaneous Use.
Standing Out
We inspire trust, hope, and confidence through our work, delivering meaningful advancements in care that positively impact both patients and healthcare providers. Our story is one of dedication, innovation, and consistent support in improving health outcomes.
A Specialty Care Team
Our team is composed of leading clinical and commercial experts who collaborate to ensure the highest quality of cardiovascular and renal care:
scPharmaceuticals specializes in managing chronic conditions with a dedication to patient-centric care, enhancing access to transformative cardiorenal therapies
Our deep experience in crafting drug/device combination and specialty products offers unique solutions that stand out in the healthcare market
Committed to advancing the field of cardiorenal medicine, we are driven to address unmet medical needs and improve patient outcomes for those with chronic cardiovascular and renal conditions
Strong Industry Connections
We have strong relationships with regulators, healthcare professionals, and key opinion leaders alongside our network of payers, providers, foundations, and patient advocacy groups, allowing us to navigate the market seamlessly and provide smooth product introductions, expansions for therapies, and addressing unmet medical needs for treating chronic cardiorenal
conditions.
